Related Experiment Videos
Molecular heterogeneity in McArdle's disease
S M McConchie1, J Coakley, R H Edwards
1Muscle Research Centre, Department of Biochemistry, University of Liverpool, U.K.
Biochimica Et Biophysica Acta
|November 14, 1990
Summary
McArdle's disease, a muscle glycogen phosphorylase deficiency, shows molecular heterogeneity. Some patients express phosphorylase mRNA and low protein levels, indicating varied genetic presentations of this congenital disorder.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- McArdle's disease is a congenital deficiency of muscle glycogen phosphorylase.
- This enzyme is crucial for glycogenolysis in muscle tissue.
- Understanding the molecular basis of McArdle's disease is important for diagnosis and potential therapies.
Purpose of the Study:
- To investigate the molecular basis of McArdle's disease in eleven patients.
- To determine the expression levels of phosphorylase protein, its cofactor, and mRNA.
- To explore the potential for molecular heterogeneity in the disease phenotype.
Main Methods:
- Muscle biopsies were obtained from eleven patients diagnosed with McArdle's disease.
- Western blotting was used to screen for phosphorylase protein.
- Northern blotting was employed to detect phosphorylase mRNA and assess cofactor levels.
Main Results:
- Three out of eleven patients showed near-normal levels and size of phosphorylase mRNA.
- One of these patients also exhibited low levels of phosphorylase protein.
- This patient demonstrated a small but measurable level of enzyme activity.
Conclusions:
- The findings suggest significant molecular heterogeneity in McArdle's disease.
- The presence of mRNA and some protein indicates varied genetic underpinnings.
- This heterogeneity may influence disease presentation and progression.